Abstract:Background: Psoriasis is one of the chronic and autoimmune skin diseases. It is important to uncover the mechanisms underlying the psoriasis. Transcription factor activator protein (TFAP-2) gamma, also known as AP2-gamma, is a protein encoded by the TFAP2C gene. Immunemediated pathophysiological processes could be linked to psoriasis, but the mechanism is still unclear. Therefore, to date the cause of psoriasis has not been understood completely. Materials and methods: Psoriasis is a complex disease triggered by genetic, immunological, and environmental stimuli. Keratinocytes play an important role in both initiation and maintenance phases of psoriasis. A psoriatic keratinocyte model was established by stimulating high sensitivity of human epidermal keratinocytes (HaCaT) to topoisomerase inhibitor cell lines using the accumulation of M5 cytokines comprising interleukin (IL)-17A, IL-22, oncostatin M, IL-1 alpha, and tumor necrosis factor-alpha (TNF-alpha). The TFAP2C and transcriptional enhanced associate domain 4 (TEAD4) genes expression was evaluated by reverse transcription-quantitative polymerase chain reaction. Western blot analysis was used to examine protein expression. Cell viability (quantitative) of keratinocytes, including cytotoxicity, proliferation, and cell activation, was evaluated by the MTT assay. The relative percentage values of interleukin (IL)-17a, interferon gamma, and IL-4+ cells were measured by flow cytometry. Accordingly, chromatin immunoprecipitation and luciferase reporter assays were applied to evaluate the binding affinity of TFAP2C and TEAD4 promoter. Results: Level of the TFAP2C gene was elevated in the lesional skin of psoriasis patients. On the other hand, silencing of the TFAP2C gene suppressed the proliferation and inflammatory response in M5-induced keratinocytes. In addition, inhibition of TFAP2C alleviated imiquimod (IMQ)-induced skin injury in mice model. We also observed that suppression of TFAP2C inhibited the activation of T-helper 17 (Th17) and Th1 cells in IMQ-induced mice model. Mechanically, TFAP2C promoted TEAD4 transcriptional activation. Conclusion: TFAP2C exacerbated psoriasis-like inflammation by increasing the activation of Th17 and Th1 cells by regulating TEAD4 transcription. This finding clearly indicated that TFAP2C could be considered a valuable biomarker for the prevention and treatment for psoriasis. (c) 2023 Codon Publications. Published by Codon Publications.

Suppression of TCF4 promotes a ZC3H12A-mediated self-sustaining inflammatory feedback cycle involving IL-17RA/IL-17RE epidermal signaling

TAOK1 Negatively Regulates IL-17-mediated Signaling and Inflammation

Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state

IL-17A Signaling in Colonic Epithelial Cells Inhibits Pro-Inflammatory Cytokine Production by Enhancing the Activity of ERK and PI3K.

The transcription factor Zfp281 sustains CD4 + T lymphocyte activation through directly repressing Ctla-4 transcription

IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17–Regulated mRNA Stabilization

Diminished γδ T Cells during allergic skin inflammation is mediated by IL-4 signaling in keratinocytes

A Novel IL-17 Signaling Pathway Controlling Keratinocyte Proliferation and Tumorigenesis Via the TRAF4–ERK5 Axis

<i>TFAP2C</i> exacerbates psoriasis-like inflammation by promoting Th17 and Th1 cells activation through regulating <i>TEAD4</i> transcription

T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts

T cells promote distinct transcriptional programs of cutaneous inflammatory disease in human skin structural cells

Elucidating The Role Of Interleukin-17f In Cutaneous T-Cell Lymphoma

Zdhhc2 Is Essential for Plasmacytoid Dendritic Cells Mediated Inflammatory Response in Psoriasis

Regulatory T cells promote innate inflammation after skin barrier breach via TGF-β activation

The TCRs of pathogenic Th17 cells in arthritogenic mice are shifted toward a Treg-like repertoire

The transcription regulators ZNF750 and LSD1/KDM1A dampen inflammation on the skin's surface by silencing pattern recognition receptors

IL-1 Signaling Regulates Skin Inflammation Through Directly Activating and Indirectly Chemoattracting Dermal Γδ T17 Cells (CAM1P.147)

Crucial Role for Nuclear Factor of Activated T Cells in T Cell Receptor-Mediated Regulation of Human Interleukin-17.

CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation

Protein Palmitoylation by ZDHHC13 Protects Skin against Microbial-Driven Dermatitis

IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation